Riskpilot← Back to searchSign inGet full accessINDUVITA AS
ASActiveOrg 929782933Sjøgata 15, 8006 BodøResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20223 employees
Revenue 2024
NOK 315K
EBITDA margin
-285.2%
+22% vs 2023
Equity ratio
57.4%
Financial strength
Net profit 2024
NOK -874K
+7% vs 2023
| Revenue | NOK 315K | — |
| EBITDA | NOK -899K | +22% |
| Net profit | NOK -874K | +7% |
| Total assets | NOK 8,3M | +32% |
| Equity | NOK 4,7M | +28% |
| Employees | 3 | — |
Legal name
INDUVITA AS
Org number
929782933
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
6. september 2022
Share capital
NOK 69 331
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Stine andreasen
Company purpose
Utvikle medisinsk utstyr innen kvinnehelse, både til bruk i pasientbehandling og opplæringsøyemed, og liknende virksomhet.
Address
Sjøgata 15, 8006 Bodø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 50 | 0 | 315 |
| Staff expenses | −0 | −125 | −123 |
| EBITDA | −59 | −1 160 | −899 |
| Depreciation & amort. | −0 | −0 | −229 |
| EBIT | −59 | −1 160 | −1 128 |
| Net financials | 0 | −45 | −10 |
| Profit before tax | −59 | −1 205 | −1 137 |
| Tax | −0 | −265 | −263 |
| Net profit | −59 | −940 | −874 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 78 | 6 247 | 8 271 |
| Equity | −29 | 3 714 | 4 744 |
| Long-term debt | 0 | 2 000 | 2 000 |
| Short-term debt | 107 | 533 | 1 527 |
| Total debt | 107 | 2 533 | 3 527 |
EBITDA margin
-285.2%
This company
15.8%
Market median
-1905% vs market
20222024
Equity ratio
57.4%
This company
38.2%
Market median
+50% vs market
20222024
Return on equity
-18.4%
This company
18.4%
Market median
-200% vs market
20222024
Net profit margin
-277.2%
This company
8.1%
Market median
-3522% vs market
20222024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20222024
Debt / equity
0.74×
This company
0.62×
Market median
+19% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HH Chief Executive Officer | Chief Executive Officer | 2023 |
BS Observer | Observer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2026 | |
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Board of Directors | 2024 | |
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Former (1) | ||
| Board of Directors | 2023 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 24.5% | 24.5% | 2024 | |
| Company | 24.5% | 24.5% | 2024 | |
| Individual | 24.5% | 24.5% | 2024 | |
| Company | 5.49% | 5.49% | 2024 | |
| Company | 5.03% | 5.03% | 2024 | |
| Company | 3.47% | 3.47% | 2024 | |
| Company | 3.44% | 3.44% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of INDUVITA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hege Hansen | Chief Executive Officer | 0 companies |
| Beate Sørslett | Observer | 0 companies |
| Edvard Hjort Iversen | Board of Directors | 0 companies |
| Helle Moen | Chairman | 0 companies |
| Morten Skjelbred | Board of Directors | 0 companies |
| Bjørn Olsen | Board of Directors | 0 companies |
| Stine Andreasen | Board of Directors | 0 companies |
| Cristina Kvam Santos | Board of Directors | 0 companies |
| Svenn Are Jenssen | Board of Directors | 0 companies |